Showing results (51-60 of 83) with videos related to
Sort By:
Pageof 9
European Journal of Cancer (Oxford, England : 1990)|July 16, 2011
Management and treatment of triple-negative breast cancer patients from the NEMESI study: an Italian experienceV Adamo, G R R Ricciardi, S De Placido, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 23, 1998
A phase II study of irinotecan alternated with five days bolus of 5-fluorouracil and leucovorin in first-line chemotherapy of metastatic colorectal cancerE Van Cutsem, C Pozzo, H Starkhammar, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1992
A phase II trial of 10-ethyl-10-deaza-aminopterin, a novel antifolate, in patients with advanced and/or recurrent squamous cell carcinoma of the head and neck. The EORTC Head and Neck Cancer Cooperative GroupJ H Schornagel, J Verweij, P H de Mulder, et al.Oncology|April 15, 2010
Clinical significance of PTEN and p-Akt co-expression in HER2-positive metastatic breast cancer patients treated with trastuzumab-based therapiesAlessandra Fabi, G Metro, A Di Benedetto, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 5, 2001
Identification of the highest dose of docetaxel associable with active doses of epirubicin. Results from a dose-finding study in advanced breast cancer patientsM Venturini, A Michelotti, P Papaldo, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1994
Randomized comparison of cisplatin, methotrexate, bleomycin and vincristine (CABO) versus cisplatin and 5-fluorouracil (CF) versus cisplatin (C) in recurrent or metastatic squamous cell carcinoma of the head and neck. A phase III study of the EORTC Head and Neck Cancer Cooperative GroupM Clavel, J B Vermorken, F Cognetti, et al.Cancer Investigation|December 9, 2009
In situ protein expression of RRM1, ERCC1, and BRCA1 in metastatic breast cancer patients treated with gemcitabine-based chemotherapyG Metro, Z Zheng, A Fabi, et al.American Journal of Clinical Oncology|April 25, 2000
Toxicity and activity of docetaxel in anthracycline-pretreated breast cancer patients: a phase II studyV Ferraresi, M Milella, A Vaccaro, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1995
Randomized phase III trial of edatrexate versus methotrexate in patients with metastatic and/or recurrent squamous cell carcinoma of the head and neck: a European Organization for Research and Treatment of Cancer Head and Neck Cancer Cooperative Group studyJ H Schornagel, J Verweij, P H de Mulder, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2000
Patients treated with antitumor drugs displaying neurological deficits are characterized by a low circulating level of nerve growth factorS De Santis, A Pace, L Bove, et al.Pageof 9